456 related articles for article (PubMed ID: 7538087)
1. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.
Muñoz A; Gallart T; Usac EF; Fernández-Alvarez J; Viñas O; Somoza N; Barceló J; Gomis R
Diabetologia; 1995 Jan; 38(1):62-72. PubMed ID: 7538087
[TBL] [Abstract][Full Text] [Related]
2. CD5+ B lymphocytes in high-risk islet cell antibody-positive and newly diagnosed IDDM subjects.
Schatz DA; Lang F; Cantor AB; Riley WJ; Maclaren NK; Sleasman JW; Barrett DJ
Diabetes; 1991 Oct; 40(10):1314-8. PubMed ID: 1718800
[TBL] [Abstract][Full Text] [Related]
3. Frequency of B cells committed to the production of antibodies to insulin in newly diagnosed patients with insulin-dependent diabetes mellitus and generation of high affinity human monoclonal IgG to insulin.
Casali P; Nakamura M; Ginsberg-Fellner F; Notkins AL
J Immunol; 1990 May; 144(10):3741-7. PubMed ID: 2159034
[TBL] [Abstract][Full Text] [Related]
4. Fetal type lymphocytes in insulin dependent diabetes mellitus.
Gyarmati J; Szekeres-Barthó J; Fischer B; Soltész G
Autoimmunity; 1999; 30(2):63-9. PubMed ID: 10435718
[TBL] [Abstract][Full Text] [Related]
5. Islet cell and 64K autoantibodies are associated with plasma IgG in newly diagnosed insulin-dependent diabetic children.
Gerling I; Baekkeskov S; Lernmark A
J Immunol; 1986 Dec; 137(12):3782-5. PubMed ID: 3537124
[TBL] [Abstract][Full Text] [Related]
6. Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.
Kasaian MT; Ikematsu H; Casali P
J Immunol; 1992 May; 148(9):2690-702. PubMed ID: 1374094
[TBL] [Abstract][Full Text] [Related]
7. Enhanced percentage of CD5+ B lymphocytes in newly diagnosed IDDM patients.
Nicoletti F; Meroni PL; Barcellini W; Steinsväg PO; Di Mauro M; Lunetta M; Pagano M; Consoli U; Zanussi C
Immunol Lett; 1990 Jan; 23(3):211-5. PubMed ID: 1689697
[TBL] [Abstract][Full Text] [Related]
8. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.
Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal autoantibodies from insulin-dependent diabetic patients: autoantibodies against beta-cell surface or cytoplasmic antigens.
Houssaint E; Pogu S; Ouary M; Sai P
Clin Exp Immunol; 1990 Oct; 82(1):44-51. PubMed ID: 1698582
[TBL] [Abstract][Full Text] [Related]
10. Monoreactive and polyreactive rheumatoid factors produced by in vitro Epstein-Barr virus-transformed peripheral blood and synovial B lymphocytes from rheumatoid arthritis patients.
Burastero SE; Cutolo M; Dessì V; Celada F
Scand J Immunol; 1990 Oct; 32(4):347-57. PubMed ID: 1700467
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
[TBL] [Abstract][Full Text] [Related]
12. Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first-degree relatives of type 1 (insulin-dependent) diabetic patients.
Nicoletti F; Scalia G; Lunetta M; Condorelli F; Di Mauro M; Barcellini W; Stracuzzi S; Pagano M; Meroni PL
Clin Immunol Immunopathol; 1990 Apr; 55(1):139-47. PubMed ID: 2155076
[TBL] [Abstract][Full Text] [Related]
13. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus.
Nakamura M; Burastero SE; Ueki Y; Larrick JW; Notkins AL; Casali P
J Immunol; 1988 Dec; 141(12):4165-72. PubMed ID: 2848890
[TBL] [Abstract][Full Text] [Related]
14. Immunological studies in children with type I diabetes mellitus and their healthy relatives: in vitro antigen stimulated IgM production, T-cell subsets and islet-cell antibodies.
Etzioni A; Vardi P; Benderly A; Katz R; Pollack S
J Clin Lab Immunol; 1987 Dec; 24(4):163-6. PubMed ID: 3329227
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
16. Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors.
Mantovani L; Wilder RL; Casali P
J Immunol; 1993 Jul; 151(1):473-88. PubMed ID: 7686945
[TBL] [Abstract][Full Text] [Related]
17. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
DeAizpurua HJ; Honeyman MC; Harrison LC
J Autoimmun; 1992 Dec; 5(6):759-70. PubMed ID: 1489487
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition.
Kasaian MT; Casali P
Autoimmunity; 1993; 15(4):315-29. PubMed ID: 7511005
[TBL] [Abstract][Full Text] [Related]
19. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
[TBL] [Abstract][Full Text] [Related]
20. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
